Christopher Grant Doughty
Insider Reports History
- Location
- Waltham, MA
- Signature
- /s/ Barbara Bispham, as attorney-in-fact for Christopher Doughty
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Christopher Grant Doughty:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. | Chief Business Officer | Ordinary Shares | 62,194 | $937,885 | $15.08 | 15 Dec 2025 | Direct |
| CRESCENT BIOPHARMA, INC. | Chief Business Officer | Stock Option (Right to Buy) | 58,855 | 15 Dec 2025 | Direct |
Insider Reports Filed by Christopher Grant Doughty
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLYC | CRESCENT BIOPHARMA, INC. | 15 Dec 2025 | 3 | $0 | 4 | Chief Business Officer | 17 Dec 2025, 16:47 |
| GLYC | GLYCOMIMETICS INC | 13 Jun 2025 | 0 | $0 | 3 | Chief Business Officer | 23 Jun 2025, 18:29 |